Skip to main content
. 2023 Oct 3;4(5):e387. doi: 10.1002/mco2.387

FIGURE 3.

FIGURE 3

Circulating immune cells biomarkers of response for antitumor immunotherapy. Peripheral blood immune cells (such as CD8+, CD4+, NK, NKT, B, Tregs, DCs, and MDSC cells) have been identified as potential biomarkers in immunotherapy. PD‐L1, programmed cell death ligand‐1; HLA, human leukocyte antigen; NK cells, natural killer cells; DCs, classical dendritic cells; MDSCs, myeloid‐derived suppressor cells; Tregs, regulatory T cells (www.biorender.com).